BDP® 650/665 alkyne
Cat. # | Quantity | Price | Lead time | Buy this product |
---|---|---|---|---|
A84B0 | 1 mg | $125 | in stock | |
B84B0 | 5 mg | $260 | in stock | |
C84B0 | 10 mg | $325 | in stock | |
D84B0 | 25 mg | $510 | in stock | |
E84B0 | 50 mg | $895 | in stock | |
F84B0 | 100 mg | $1490 | in stock |
BDP 650/665 alkyne is a red-emitting BDP dye derivative carrying a terminal alkyne group for a copper-catalyzed conjugation with azides. Absorption and emission spectra of BDP 650/665 are designed to fit Cy5-channel of various instruments.
Absorption and emission spectra of BDP 650/665
Recommended protocol
Calculator
Customers also purchased with this product
BDP® TMR azide
Borondipyrromethene dye with azido group. Spectral properties are similar to TAMRA dye. Due to long fluorescence lifetime, BDP TMR is especially useful for fluorescence polarization measurements.TAMRA alkyne, 5-isomer
Alkyne derivative of TAMRA dye, pure 5-isomer for сopper-catalyzed сlick chemistry.BDP® TR alkyne
BDP TR is a fluorophore for ROX channel. This borondipyrromethene dye is very bright, and resistant to oxidation.General properties
Appearance: | dark colored solid |
Molecular weight: | 470.28 |
CAS number: | 2006345-40-8 |
Molecular formula: | C26H21N4BF2O2 |
Solubility: | soluble in DMF, DMSO |
Quality control: | NMR 1H, HPLC-MS (95%) |
Storage conditions: | Storage: 24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Avoid prolonged exposure to light. Desiccate. |
MSDS: | Download |
Product specifications |
Spectral properties
Excitation/absorption maximum, nm: | 649 |
ε, L⋅mol−1⋅cm−1: | 94000 |
Emission maximum, nm: | 667 |
Fluorescence quantum yield: | 0.52 |
CF260: | 0.04 |
CF280: | 0.04 |
Product citations
- Iacobazzi, R.M.; Arduino, I.; Di Fonte, R.; Lopedota, A.A.; Serratì, S.; Racaniello, G.; Bruno, V.; Laquintana, V.; Lee, B.-C.; Silvestris, N.; Leonetti, F.; Denora, N.; Porcelli, L.; Azzariti, A. Microfluidic-Assisted Preparation of Targeted pH-Responsive Polymeric Micelles Improves Gemcitabine Effectiveness in PDAC: In Vitro Insights. Cancers, 2022, 14(1), 5. doi: 10.3390/cancers14010005
BDP® is a trademark of Lumiprobe
This Product is offered and sold for research purposes only. It has not been tested for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. Supply does not express or imply authorization to use for any other purpose, including, without limitation, in vitro diagnostic purposes, in the manufacture of food or pharmaceutical products, in medical devices or in cosmetic products.
Your item has been added.
View your
cart
or
proceed to checkout
The count of items is incorrect.